1. Home
  2. MMS vs STVN Comparison

MMS vs STVN Comparison

Compare MMS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$65.65

Market Cap

3.6B

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$13.46

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMS
STVN
Founded
1975
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Business Services
Containers/Packaging
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.0B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
MMS
STVN
Price
$65.65
$13.46
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
631.0K
506.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.01%
0.46%
EPS Growth
10.42
N/A
EPS
1.70
N/A
Revenue
$2,392,236,000.00
N/A
Revenue This Year
$0.44
$9.67
Revenue Next Year
$5.15
$9.99
P/E Ratio
$38.69
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$60.75
$12.89
52 Week High
$100.00
$28.00

Technical Indicators

Market Signals
Indicator
MMS
STVN
Relative Strength Index (RSI) 38.31 35.61
Support Level $60.75 $12.89
Resistance Level $89.28 $16.69
Average True Range (ATR) 2.19 0.63
MACD 0.47 0.03
Stochastic Oscillator 49.10 24.56

Price Performance

Historical Comparison
MMS
STVN

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

Share on Social Networks: